The world’s largest conference on HIV/AIDS, AIDS 2022, convenes July 27-August 2 in Montreal, Canada, (register for the full conference and the pre-conference). Hosted by the International AIDS Society, this 24th session of the conference will be the first since the pandemic to offer in-person and virtual access.
AIDS 2022 launches at a pivotal moment in HIV prevention. The ability to deliver two new proven PrEP methods will be determined by conversations and decisions happening now. These decisions will impact policies and funding for products in the pipeline and programs to deliver what’s available today for HIV prevention. It’s time to sharpen the agenda for HIV prevention and global health equity. AIDS 2022 will offer opportunities to engage in these conversations while getting up to date on the latest research, rollout, policy and advocacy.
Below AVAC has gathered resources to help you navigate the conference overall and find the sessions on prevention that we hope will interest you, keep you informed, and support conversations that will shape the future of the global response to HIV.
- Use AVAC’s Prevention Roadmap for a curated map on all things prevention at AIDS2022. You can download it as a sortable spreadsheet or PDF.
- AVAC’s Research-to-Rollout Literacy Networking Zone will offer in-person and virtual programming. See the schedule.
- Follow events in real time on Twitter at #AIDS2022. See AVAC’s comments and updates by following us at @HIVpxresearch, find updates on this page throughout the conference, and get the latest news from our friends at NAM/aidsmap who will be reporting throughout the conference.
Panels, Satellites, Sessions and Workshops Featuring AVAC and Partners
[INSERT AIDS 2022 LOGO]
Friday, July 29
- [Satellite] PrEP-ing for 2025: Why optimization and scale-up of the PrEP service and product mix is critical to addressing unmet PrEP need and supporting effective use towards 2030 HIV prevention goals
Highlighting exciting advances in PrEP delivery from using demedicalized, simplified and integrated services and person-centered care. PrEP users, implementers, advocates, and researchers discuss how speeding access to newer PrEP products in lower-middle-income countries will propel achievement of 2025 goals.
- [Satellite] Experimental medicine clinical trials in Africa: considerations and community engagement
A look into ethical challenges and community perspectives when conducting experimental medicine trials for preventive HIV vaccines in Africa. It will explore ways of communicating and meaningfully engaging with communities about experimental medicine trials.
- [Satellite] Accessing long-acting HIV prevention and treatment innovations: Landscape, service delivery, and pathways to affordability
Bringing together key stakeholders from ministries of health, civil society, industry, communities, funders, implementers, and researchers to discuss the differentiated service delivery models that can be used to ensure the current toolkit of prevention and treatment options reach communities who are vulnerable to HIV and do not burden the healthcare system.
- [Satellite] What’s new in WHO guidelines: innovations, access and monitoring
Presentation of new WHO guidelines focusing on innovations, access and person-centered monitoring in HIV services, including the launch of recommendations on injectable PrEP.
- [Satellite] Next Generation PrEP: Science, policy, and community impact
How do clinical trials assess efficacy of new and still-needed experimental products, with highly effective options available to the public? This session explores the need to bring key stakeholders including communities, industry and regulators to questions such as: How do regulators approach groundbreaking new trial designs in HIV prevention? How do these trial designs affect patients in the trials and those that may benefit from candidate drugs?
Saturday, July 30
- [Symposium] Equitable roll out of health products: What will it take?
Discussing innovative strategies, collaborative partnerships and transparent processes that engage advocates, government agencies, policy makers, government and non-governmental funders, regulatory bodies and pharmaceutical companies and result in equitable access to new products, the key to achieving rapid and effective product rollout.
Sunday, July 31
- [Satellite] A new global Roadmap for combination HIV prevention. Intensified actions towards achieving UNAIDS 2025 targets
Launch of the Global Prevention Coalition’s new 2025 HIV Prevention Roadmap.
[INSERT MOSAIC TILE]
- [Workshop] Our next shot: Effectively delivering injectable cabotegravir for PrEP (in-person only)
Explore what is needed to ensure that introductory research and programmes are strategically designed, user-centered and appropriately resourced to support successful roll out of CAB for PrEP. Co-convened by MOSAIC and WHO in partnership with EpiC, RISE, CASPR and BioPIC.
[INSERT DPP TILE]
- [Satellite] Demand, delivery and data for decision-making: How market preparation for the Dual Prevention Pill is reimagining prevention programs for a future with MPTs
A discussion on how to practically align HIV and FP programs and services to deliver the dual prevention pill (DPP), a multi-purpose prevention technology (MPT) in development, combining oral contraception with oral PrEP.
Monday, August 1
- [Satellite] What has COVID-19 changed in vaccine R&D and what remains to change for an HIV vaccine?
Will look at what lessons learnt from COVID-19 vaccine development can be applied to HIV vaccine development.
Watch this space for new opportunities to come together and shape what happens next!